Wei Song
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Biomaterials top 5%
- Molecular Medicine top 5%
- Biomedical Engineering top 2%
- 3D Printing in Biomedical Research 30
- Cell Biology top 5%
- Cellular Mechanics and Interactions 11
-
- RNA modifications and cancer 13
-
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 8
-
- Pancreatic function and diabetes 7
- Tissue Engineering and Regenerative Medicine 6
- Journals
- Oncotarget (6 papers)Burns & Trauma (6 papers)International Journal of Biological Macromolecules (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Wei Song
115 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 579
- Biomaterials 408
- Molecular Medicine 151
- Biomedical Engineering 1.2k
- Cell Biology 363
Countries citing papers authored by Wei Song
This map shows the geographic impact of Wei Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Song more than expected).
Fields of papers citing papers by Wei Song
This network shows the impact of papers produced by Wei Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Song. The network helps show where Wei Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 49 | |
| 13 | 2020 | 80 | |
| 14 | 2020 | 45 | |
| 15 | 2020 | 87 | |
| 16 | 2019 | 85 | |
| 17 | 2019 | 86 | |
| 18 | 2013 | 33 | |
| 19 | 2009 | 18 | |
| 20 | Mutation analysis of mitochondrial DNA in colorectal carcinoma tissues by silver-staining PCR-SSCP | 2006 | 2 |
About Wei Song
Wei Song is a scholar working on Cancer Research, Cell Biology and Oncology, having authored 121 papers that have together received 3.3k indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (30 papers), RNA modifications and cancer (13 papers), Cellular Mechanics and Interactions (11 papers), Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), MicroRNA in disease regulation (7 papers), Pancreatic function and diabetes (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). The work is most often cited by research in Cancer Research (579 citations), Biomaterials (408 citations) and Molecular Medicine (151 citations). Wei Song has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Minglin Ma, Sha Huang, Bin Yao, Xiaobing Fu, Duo An, Naoki Kawazoe, Guoping Chen, Jiuwei Cui, Tian Hu and Alan Chiu. Their work appears in journals such as Oncotarget, Burns & Trauma, International Journal of Biological Macromolecules, Nature Communications and Soft Matter.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.